| Latest Safeguard Scientific News Headlines | | Date | Time | Source | | | 05/18/2009 | 9:00AM | PRNUS | Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners
$40 Million in Total Proceeds Retire Safeguard Mezzanine Debt Facility; Support Profitable Growth
ALISO VIEJO, Calif., May 18 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, announced... More...>> |
| 03/26/2009 | 4:15PM | PRNUS | Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners
Proceeds to Retire Safeguard and Comerica Debt Facilities; Support Robust Growth
ALISO VIEJO, Calif., March 26 /PRNewswire-FirstCall/ -- Clarient, Inc., (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, announced today that... More...>> |
| 03/04/2009 | 8:30AM | PRNUS | Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and We
ALISO VIEJO, Calif., March 4 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it has rescheduled the release of its financial results for the fourth quarter and year-ended December 31... More...>> |
| 03/03/2009 | 6:00AM | PRNUS | Clarient Renews and Expands Mezzanine Credit Facility With Safeguard
ALISO VIEJO, Calif., March 3 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that, effective February 27, 2009, the Company has renewed, expanded and extended its... More...>> |
| 07/31/2008 | 5:04PM | PRNUS | Excerpts of Video Interviews from the Nortia Capital Partners Equities Conference Available for Viewing on NEXTinvestor.com
NEW YORK, July 31 /PRNewswire/ -- NEXTinvestor.com announced today that the CEOs and leaders of 5 companies were interviewed at the Nortia Capital Equities Conference in Atlantic City, NJ on July 14-15, 2008. The companies delivered presentations at Bally's Hotel and Casino during a three-day conference, and executives... More...>> |
| 07/01/2008 | 6:00AM | PRNUS | Clarient Launches New Colorectal Cancer Test
KRAS Test Identifies Mutation that Signals a Patient's Potential Response to Specific Drug Therapies
ALISO VIEJO, Calif., July 1 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry... More...>> |
| 05/29/2008 | 7:30AM | PRNUS | Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer
ALISO VIEJO, Calif., May 29 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that, effective June 5th, veteran financial executive Raymond J. Land, 63, will join... More...>> |
| 05/22/2008 | 6:00AM | PRNUS | Jim Agnello to Resign as Clarient Chief Financial Officer
ALISO VIEJO, Calif., May 22 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that its Senior Vice President and Chief Financial Officer, Jim Agnello, will step down... More...>> |
| 05/06/2008 | 6:00AM | PRNUS | Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays
Agreement Generates New Diagnostic Opportunities at 120 Hospital-Affiliated Labs Nationwide
ALISO VIEJO, Calif., May 6 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced... More...>> |
| 04/30/2008 | 4:15PM | PRNUS | Clarient Reports First Quarter 2008
Generates Year-over-Year Revenue Increase of 80%; Gross Profit Improves 161%; Operating Loss Declines by 96%
ALISO VIEJO, Calif., April 30 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical... More...>> |
| 04/28/2008 | 4:30PM | PRNUS | Clarient Continues to Augment Organization to Support Profitable Growth
COO Appointed President; CEO Named Vice Chairman of the Board of Directors
ALISO VIEJO, Calif., April 28 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that Michael J. Pellini, M.D. has... More...>> |
| 04/10/2008 | 7:00AM | PRNUS | Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
- Laureate To Manufacture Alopexx's Product Candidate -
PRINCETON, N.J., April 10, 2008 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has entered into a cGMP contract manufacturing agreement with Alopexx Pharmaceuticals, LLC... More...>> |
| 04/01/2008 | 7:00AM | PRNUS | Laureate Pharma Reports Record Growth for 2007
Continued Momentum Results in 131.4% Increase in Revenue and Positive EBITDA for Three Consecutive Quarters
PRINCETON, N.J., April 1 /PRNewswire/ -- Laureate Pharma, Inc., a full- service biopharmaceutical development and protein production company, today announced record growth in revenues for 2007. The company posted... More...>> |
| 03/31/2008 | 7:15AM | PRNUS | Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
Quarterly Revenue and Case Volumes Increase 53% and 52% Respectively Year-over-Year
ALISO VIEJO, Calif., March 31 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced financial results for the... More...>> |
| 03/27/2008 | 12:00PM | PRNUS | Clarient to Present at the B. Riley & Co. 9th Annual Las Vegas Investor Conference
ALISO VIEJO, Calif., March 27 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make an investor presentation at the B. Riley & Co. 9th Annual Las Vegas Investor Conference... More...>> |
| 03/27/2008 | 7:00AM | PRNUS | Laureate Announces Second Manufacturing Agreement with Cytheris
Laureate to Manufacture Cytheris' Lead Product Candidate, INTERLEUKIN-7, currently in clinical trials for treatment of HIV, HCV and cancer
PRINCETON, N.J. and PARIS, March 27 /PRNewswire-FirstCall/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, announced today... More...>> |
| 02/28/2008 | 11:19AM | PRNUS | American Capital Invests in NextPoint(TM) Networks
BETHESDA, Md., Feb. 28 /PRNewswire-FirstCall/ -- American Capital Strategies Ltd. (NASDAQ:ACAS) announced today that in January it and its affiliates invested in NextPoint(TM) Networks, Inc. NextPoint is the result of the convergence of NexTone Communications, a leader in software-centric session border controllers... More...>> |
| 01/31/2008 | 7:00AM | PRNUS | Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
- Laureate to Manufacture ARIUS' Product Candidate Trop-2 Signal Transduction Antibody -
PRINCETON, N.J., Jan. 31 /PRNewswire/ -- Laureate Pharma, Inc., a full- service biopharmaceutical development and protein production company, today announced that it has entered into a cGMP contract manufacturing agreement with... More...>> |
| 01/31/2008 | 6:00AM | PRNUS | CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
The HemeScan(TM) Test Provides Prognostic Marker Precision and Simultaneous Diagnostic Monitoring
MUKILTEO, Wash. and ALISO VIEJO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- CombiMatrix Corporation (NASDAQ:CBMX) and Clarient, Inc. (NASDAQ:CLRT) today jointly announced establishment of a strategic partnership to market... More...>> |
| 01/14/2008 | 2:29PM | PRNUS | Portico Systems to Share Provider Network Management Best Practices at Health IT Insight
Event features exclusive content from IDC's Health Industry Insights
PHILADELPHIA, Jan. 14 /PRNewswire/ -- Nanci Ziegler, EVP of market strategy and business development for Portico Systems, the leader in Provider Network Management solutions, will present a "A Case Study in Optimizing Provider Network Management" at... More...>> |
|